Ocular HSV-1 is a leading cause of corneal blindness due to an infectious agent. Our long term goal is to understand how HSV-1 evades the immune response thereby enhancing latency and recurrent disease even in the face of local and systemic immunity. The antigen presenting dendritic cells (DC) play a central role in initiation and modulation of local and systemic immunity. HSV-1 can infect DC and interfere with their maturation (a process critical to DC function). This may help HSV-1 evade the host immune response. As the only HSV-1 gene abundantly transcribed at all times, LAT is a candidate, for modulating DC activity during both acute and latent infection. Preliminary studies suggest that LAT can alter DC cytokine expression. Thus, LAT can affect DC. We hypothesize here that LAT is critical for HSV-1's ability to interfere with DC maturation. We further hypothesize that HSV-1 can inhibit DC trafficking (another critical DC function), and that LAT is also critical for this viral activity. If correct, these hypotheses would reveal a novel immune evasion strategy and open new doors to novel immunotherapeutic interventions against acute and recurrent HSV-1 infections. This would lead to the development of methods to greatly alleviate suffering and loss of vision due to recurrent ocular HSV-1.
Our Specific Aims i nclude: 1. Determine if the ability of HSV-1 to interfere with DC maturation is due to LAT. In vitro and in vivo studies will be done to determine if infection of DC with HSV-1 LAT+, but not HSV-1 LAT-, will block membrane expression of MHC and co-stimulatory molecules, and inhibit HSV and non-HSV antigen presentation by DC. The ability of plasmids expressing LAT to block MHC and co-stimulatory molecule expression and inhibit antigen presentation will also be examined. 2: Determine if LAT alters DC migration. (a)Determine if LAT modulates cytokine and chemokine secretion by DC and chemokine-receptor expression on DC, all of which are involved in migratory activity of DC. (b)Determine if LAT changes the observed migratory activity of DC.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Small Research Grants (R03)
Project #
7R03EY014017-02
Application #
6623335
Study Section
Special Emphasis Panel (ZEY1-VSN (01))
Program Officer
Shen, Grace L
Project Start
2002-04-01
Project End
2005-03-31
Budget Start
2002-09-01
Budget End
2003-03-31
Support Year
2
Fiscal Year
2002
Total Cost
$102,277
Indirect Cost
Name
University of California Irvine
Department
Ophthalmology
Type
Schools of Medicine
DUNS #
161202122
City
Irvine
State
CA
Country
United States
Zip Code
92697
Esteves, Pedro J; Abrantes, Joana; Baldauf, Hanna-Mari et al. (2018) The wide utility of rabbits as models of human diseases. Exp Mol Med 50:66
Chentoufi, Aziz Alami; Dervillez, Xavier; Dasgupta, Gargi et al. (2012) The herpes simplex virus type 1 latency-associated transcript inhibits phenotypic and functional maturation of dendritic cells. Viral Immunol 25:204-15
Dervillez, Xavier; Gottimukkala, Chetan; Kabbara, Khaled W et al. (2012) Future of an ""Asymptomatic"" T-cell Epitope-Based Therapeutic Herpes Simplex Vaccine. Future Virol 7:371-378
Chentoufi, Aziz Alami; Dervillez, Xavier; Rubbo, Pierre-Alain et al. (2012) Current trends in negative immuno-synergy between two sexually transmitted infectious viruses: HIV-1 and HSV-1/2. Curr Trends Immunol 13:51-68
Zhang, Xiuli; Dervillez, Xavier; Chentoufi, Aziz Alami et al. (2012) Targeting the genital tract mucosa with a lipopeptide/recombinant adenovirus prime/boost vaccine induces potent and long-lasting CD8+ T cell immunity against herpes: importance of MyD88. J Immunol 189:4496-509
Dasgupta, Gargi; BenMohamed, Lbachir (2011) Of mice and not humans: how reliable are animal models for evaluation of herpes CD8(+)-T cell-epitopes-based immunotherapeutic vaccine candidates? Vaccine 29:5824-36
Chentoufi, Aziz A; Kritzer, Elizabeth; Tran, Michael V et al. (2011) The herpes simplex virus 1 latency-associated transcript promotes functional exhaustion of virus-specific CD8+ T cells in latently infected trigeminal ganglia: a novel immune evasion mechanism. J Virol 85:9127-38
Chentoufi, Aziz A; Dasgupta, Gargi; Christensen, Neil D et al. (2010) A novel HLA (HLA-A*0201) transgenic rabbit model for preclinical evaluation of human CD8+ T cell epitope-based vaccines against ocular herpes. J Immunol 184:2561-71
Chentoufi, Aziz Alami; Dasgupta, Gargi; Nesburn, Anthony B et al. (2010) Nasolacrimal duct closure modulates ocular mucosal and systemic CD4(+) T-cell responses induced following topical ocular or intranasal immunization. Clin Vaccine Immunol 17:342-53
Dasgupta, Gargi; Nesburn, Anthony B; Wechsler, Steven L et al. (2010) Developing an asymptomatic mucosal herpes vaccine: the present and the future. Future Microbiol 5:1-4

Showing the most recent 10 out of 19 publications